The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry

American Heart Journal

Volumn 162, Issue 1, 2011, Pages

  Chioncel, Ovidiu ^a   Vinereanu, Dragos ^b   Datcu, Mihai ^c   Ionescu, Dan Dominic ^d   Capalneanu, Radu ^e   Brukner, Ioan ^f   Dorobantu, Maria ^g   Ambrosy, Andrew ^h   MacArie, Cezar ^a   Gheorghiade, Mihai ^h  

^a Institute of Emergecy for Cardiovascular Diseases Prof CCIliescu   (Romania)

^b Universitary Hospital   (Romania)

^c University Emergency Hospital Sf Spiridon   (Romania)

^d Centre of Cardiology   (Romania)

^e Clinic of Cardiology   (Romania)

^f Spitalul Clinic Coltea Bucuresti   (Romania)

^g Department of Internal Medicine   (Romania)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOSIMENDAN; NITRATE; NORADRENALIN;

ACUTE HEART FAILURE; ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; DISEASE REGISTRY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

EID: 79960196648     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.03.033     Document Type: Article

References (33)

1. G.M. Felker, J.D. Leimberger, and R.M. Califf Risk stratification after hospitalization for decompensated heart failure J Card Fail 10 2004 460 466
2. M. Gheorghiade, and P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
3. D. Levy, S. Kenchaiah, and M.G. Larson Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402 (Pubitemid 35239711)
4. P.S. Pang, M. Komajda, and M. Gheorghiade The current and future management of acute heart failure syndromes Eur Heart J 31 2010 784 793
5. M. Gheorghiade, C. Orlandi, and J. Burnett Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 2005 260 269 (Pubitemid 40626781)
6. J.E. Blair, F. Zannad, and M.A. Konstam Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) program J Am Coll Cardiol 52 2008 1640 1648
7. Macarie C., and Chioncel O. Studiul romanesc de prevalenta a insuficientei cardiace in populatia arondata medicilor de familie Prog Cardiol 2 2007 311 327
8. C. Macarie Epidemiologia descriptivǎ a insuficienţei cardiace in spitalele din Romania Prog Cardiol 2 2007 297 310
9. O. Chioncel Registrul Roman de Insuficienta Cardiaca Acuta; Premize,obiective, metodologie Prog Cardiol 2008 431 436
10. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
11. M.S. Nieminen, M. Bohm, and M.R. Cowie Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 384 416 (Pubitemid 40283098)
12. L. Tavazzi, A.P. Maggioni, and D. Lucci Nationwide survey on acute heart failure in cardiology ward services in Italy Eur Heart J 27 2006 1207 1215
13. M.S. Nieminen, D. Brutsaert, and K. Dickstein EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 27 2006 2725 2736 (Pubitemid 44729876)
14. F. Zannad, A. Mebazaa, and Y. Juilliere Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 2006 697 705 (Pubitemid 44754746)
15. M. Gheorghiade, W.T. Abraham, and N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226 (Pubitemid 44708052)
16. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216 (Pubitemid 40348525)
17. W.T. Abraham, K.F. Adams, and G.C. Fonarow In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64 (Pubitemid 40905130)
18. W.T. Abraham, G.C. Fonarow, and N.M. Albert Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) J Am Coll Cardiol 52 2008 347 356 (Pubitemid 352005813)
19. A. Rudiger, V.P. Harjola, and A. Muller Acute heart failure: clinical presentation, one-year mortality and prognostic factors Eur J Heart Fail 7 2005 662 670 (Pubitemid 40733001)
20. K. Siirila-Waris, J. Lassus, and J. Melin Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure Eur Heart J 27 2006 3011 3017 (Pubitemid 44950446)
21. S.A. Hunt, W.T. Abraham, and M.H. Chin Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 2009 53 2009 e1 e90
22. P. Jain, B.M. Massie, and W.A. Gattis Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization Am Heart J 145 2003 S3 17
23. U. Elkayam, G. Tasissa, and C. Binanay Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 2007 98 104 (Pubitemid 44880871)
24. G.M. Felker, and C.M. O'Connor Inotropic therapy for heart failure: an evidence-based approach Am Heart J 142 2001 393 401 (Pubitemid 32801622)
25. C.M. O'Connor, W.A. Gattis, and B.F. Uretsky Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 1 Pt 1 1999 78 86 (Pubitemid 29331125)
26. G.C. Fonarow, K.F. Adams Jr., and W.T. Abraham Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580 (Pubitemid 40171239)
27. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587 (Pubitemid 37443288)
28. L. Klein, B.M. Massie, and J.D. Leimberger Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Circ Heart Fail 1 2008 25 33
29. R.W. Schrier Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? J Am Coll Cardiol 47 2006 1 8 (Pubitemid 43005157)
30. M. Gheorghiade, M.A. Konstam, and J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials JAMA 297 2007 1332 1343 (Pubitemid 46513234)
31. J.J. McMurray, J.R. Teerlink, and G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019 (Pubitemid 350074798)
32. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
33. N. Sato, K. Kajimoto, and K. Asai Acute Decompensated Heart Failure Syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data Am Heart J 159 2010 949 955.e1